Evaluating “Standing Tall” – An Engaging Home-based Exercise Program Using Mobile Technology For Maximizing Long-term Adherence And Preventing Falls In Older People: Randomized Controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$791,081.00
Summary
Current evidence suggests that older people have to exercise for two hours per week for six months to prevent falls, with a strong focus on balance exercises. We have developed and tested an engaging home-based balance training program delivered through mobile (tablet) technology, called ‘Standing Tall’. We propose a randomised controlled trial to examine the effectiveness of our program for preventing falls in 500 community-dwelling older people, in addition to adherence- and cost-analyses.
Cardiovascular Risk Reduction In Atrial Fibrillation (CRAFT)
Funder
National Health and Medical Research Council
Funding Amount
$153,975.00
Summary
Atrial Fibrillation (AF) affects 240,000 Australians and rates of AF are rising. AF presents a significant economic burden. AF is debilitating and increases the risk of stroke, heart failure, or premature death. People with AF have high levels of cardiovascular risk and recommendations suggest they make lifestyle changes. These recommendations are not strongly evidence based. We aim to test if a lifestyle intervention can improve adherence and develop evidence to support the recommendations.
TEXTMEDS – TEXT Messages To Improve MEDication Adherence And Secondary Prevention
Funder
National Health and Medical Research Council
Funding Amount
$1,406,875.00
Summary
TEXTMEDS will evaluate a highly innovative strategy to improve cardiovascular disease secondary prevention using cheap and widely available mobile phone technology. TEXTMEDS is a randomised controlled trial of 1400 patients with acute coronary syndrome that will examine the effect of a semi-personalised secondary prevention support program sent via mobile phone text message on the proportion taking appropriate medications for the secondary prevention of cardiovascular disease and on cardiovascul ....TEXTMEDS will evaluate a highly innovative strategy to improve cardiovascular disease secondary prevention using cheap and widely available mobile phone technology. TEXTMEDS is a randomised controlled trial of 1400 patients with acute coronary syndrome that will examine the effect of a semi-personalised secondary prevention support program sent via mobile phone text message on the proportion taking appropriate medications for the secondary prevention of cardiovascular disease and on cardiovascular risk factors levels (e.g. cholesterol).Read moreRead less